Forecast: Diabetes Medicine Use in Canada

The forecasted data for diabetes medicine use in Canada shows a steady upward trend from 2024 to 2028. In 2023, the usage was established based on historical data, setting the stage for the following years' projections. From 2024 through 2028, the medicine use in units per thousand persons per day increases significantly each year, with year-on-year variations reflecting consistent growth.

The projected values indicate a notable upward trajectory: the usage is expected to rise from 205.4 units in 2024 to 305.2 units in 2028. The annual percentage growth varies yearly but maintains an overall positive trend, underscoring the increasing demand for diabetes medication. The last five years reveal a compound annual growth rate (CAGR) that demonstrates a robust upward pattern in diabetes medicine utilization. Significant innings are:

• 205.4 units in 2024
• 230.5 units in 2025
• 255.5 units in 2026
• 280.4 units in 2027
• 305.2 units in 2028

Future trends to watch include the potential impact of new diabetes treatments and technologies, patient awareness, and lifestyle changes, which may further influence the demand for diabetes medication. Additionally, public health initiatives to manage and prevent diabetes could modulate these projections.